Rice Hall James & Associates LLC lessened its holdings in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 11.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 250,430 shares of the company's stock after selling 33,432 shares during the period. Rice Hall James & Associates LLC owned about 0.58% of Vital Farms worth $8,783,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. DekaBank Deutsche Girozentrale boosted its holdings in Vital Farms by 27.0% in the third quarter. DekaBank Deutsche Girozentrale now owns 8,301 shares of the company's stock worth $291,000 after acquiring an additional 1,763 shares in the last quarter. CWC Advisors LLC. purchased a new stake in Vital Farms in the third quarter valued at $240,000. Dakota Wealth Management acquired a new position in Vital Farms in the third quarter valued at approximately $200,000. Foresight Group Ltd Liability Partnership increased its holdings in shares of Vital Farms by 60.0% during the 3rd quarter. Foresight Group Ltd Liability Partnership now owns 15,665 shares of the company's stock valued at $549,000 after purchasing an additional 5,875 shares in the last quarter. Finally, Ellsworth Advisors LLC purchased a new position in shares of Vital Farms in the 3rd quarter valued at about $635,000. Institutional investors own 98.59% of the company's stock.
Vital Farms Trading Down 0.3 %
Shares of NASDAQ VITL traded down $0.12 during mid-day trading on Friday, reaching $34.56. 597,392 shares of the company's stock were exchanged, compared to its average volume of 749,096. The company's 50-day moving average is $34.74 and its 200-day moving average is $36.21. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.03 and a current ratio of 3.50. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 32.72 and a beta of 0.97. Vital Farms, Inc. has a 52-week low of $11.18 and a 52-week high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.20 by $0.16. Vital Farms had a return on equity of 22.77% and a net margin of 8.70%. The business had revenue of $147.39 million during the quarter, compared to analyst estimates of $138.41 million. During the same period last year, the business posted $0.15 earnings per share. The company's quarterly revenue was up 38.5% on a year-over-year basis. Analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Stifel Nicolaus lowered their target price on shares of Vital Farms from $42.00 to $34.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. DA Davidson increased their price objective on shares of Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Finally, TD Cowen upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price on the stock in a report on Friday, August 9th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.20.
Check Out Our Latest Stock Analysis on VITL
Insider Activity at Vital Farms
In related news, CEO Russell Diez-Canseco sold 44,653 shares of the stock in a transaction on Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the transaction, the chief executive officer now directly owns 537,349 shares of the company's stock, valued at $21,531,574.43. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Matthew Ohayer sold 24,000 shares of Vital Farms stock in a transaction dated Monday, October 21st. The shares were sold at an average price of $39.09, for a total value of $938,160.00. Following the sale, the insider now owns 7,194,777 shares of the company's stock, valued at $281,243,832.93. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Russell Diez-Canseco sold 44,653 shares of the firm's stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the sale, the chief executive officer now directly owns 537,349 shares of the company's stock, valued at $21,531,574.43. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 27.60% of the stock is currently owned by corporate insiders.
Vital Farms Company Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Articles
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.